Biomedical subjects

B Kellerhals

Publications and source records attributed to B Kellerhals.

At least 37 records · Page 2Linked to original sources

PubMed1977

Antibody formation by human tonsil cells in vitro.

The ability of human tonsil lymphocytes to give an anti-SRBC response in conventional cultures and in microcultures was studied. It was found that about two-thirds of tonsils responded with a significant number of plaque-forming cells (PFC), and that in some instances the response could be augmented if allogeneic tonsil cell (irradiated or intact) were added. Moreover, tonsil lymphocytes which failed to give a response on their own often responded upon addition of an appropriate number of allogeneic tonsil cells. The response was remarkably improved if allogeneic tonsil supernatant or conditioned medium were added. An anti-SRBC response was also obtained if SRBC was omitted from the cultures. The frequency of anti-SRBC specific B cells was estimated as 1/60000 (f = 1-7 X 10(-5)).

Antibodies↗

PubMed1976

Cryosurgery in vasomotor rhinopathy: experimental histopathology.

Experimental cryosurgery of the nasal mucosa in normal guinea pigss and in animals with drug-induced vasomotor rhinopathy showed complete closure of the initial ulceration by a temporary atypical epithelium within 2 week. 3-4 weeks after cryotreatment, normal ciliated epithelium covered the whole area. Within 4-5 weeks, the last signs of inflammatory reaction dinappeared. The treatment resulted in a definitive reduction of mucosal thickness, and in a numerically significant loss of vessels and glandular acini. The hintopathological results thus agreed with the clinical objective of the treatment in vasomotor rhinopathy (reduction of the nasal resistance and diminution of rhinorrhea).

Animals↗

PubMed1976

Quantitative assessment of perilymph sources.

The problem of the perilymph origin--influx of cerebrospinal fluid (CSF) versus ultrafiltration within the cochlea--cannot be solved by mere qualitative proofs of tracer passage through the cochlear aqueduct. In order to gain quantitative data on the possible perilymph sources, an experimental study was designed to follow the time course of dye concentrations in the cisternal CSF and in the perilymph after tracer injection into the CSF at the vertex. By comparing the resulting concentration peaks in both fluids, the mean peak of the perilymph tracer concentrations was found to reach 36% of the maximum CSF concentration only. It is concluded that the local perilymph production within the cochlea exceeds the influx of CSF by a ratio of about 2:1. A working hypothesis of the double perilymph origin is discussed.

Animals↗

PubMed1976

[The management of sudden deafness (author's transl)].

The mean hearing gain (125-8,000 Hz) in 46 cases of sudden deafness treated with low molecular weight dextran was found to be significantly greater (20.9 dB) than that obtained in twelve cases treated differently (9.4 dB). These alternate measures of care included stellate ganglion blockade, vasoactive drugs, sodium bicarbonate infusions, and CO2-insufflation. Early diagnosis and treatment are considered to be crucial for successful therapy: the mean hearing gain in those patients who came for dextran treatment later than one week was less than half of the gain that resulted after treatment beginning within the first week. The results obtained conform with the hypothesis of cochlear microcirculation impairment or "sludging" as the prevalent cause of sudden deafness.

Acute Disease↗

PubMed1974